Member

Crossed

PROVIREX Genome Editing Therapies GmbH

PROVIREX Genome Editing Therapies GmbH is a privately-held biotech company developing first-in-class advanced therapy medicinal products (ATMPs). PROVIREX’s technology is based on error-free genome editing for eradication of life-threatening persistent virus infection.

PROVIREX Genome Editing Therapies GmbH

Martinistraße 52
20251 Hamburg

Category

Biotechnology / Pharma